Skip to main content

← All opportunities

HEALTH AND HUMAN SERVICES, DEPARTMENT OF › NATIONAL INSTITUTES OF HEALTH › NATIONAL INSTITUTES OF HEALTH OLAO

NOI - A Non-Invasive Prognostic Biomarker - Circul

Key facts

Response deadline
Oct 23, 2026
9:00 AM UTC-04:00
Set-aside
Not stated
Notice type
Combined synopsis/solicitation
Posted on SAM.gov
Oct 13, 2026
Archives Nov 7, 2026

Description

(i)This is a combined synopsis/solicitation for commercial items prepared in accordancewith the format in FAR Subpart 12.6, as supplemented with additional information includedin this notice. This announcement constitutes the only solicitation; proposals are beingrequested, and a separate written solicitation will not be issued. (ii)The solicitation number is 75N98027Q00007. This solicitation is issued as a Notice ofIntent (NOI) for a non-competitive combined synopsis/solicitation to award a contract orpurchase order without providing for full and open competition (including brand-name, ifapplicable). This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. Additional authority includes 41 U.S.C. 1901 and FAR 6.302-3(a)(2)(ii). The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, intends to negotiate and award a firm-fixed-price purchase order on a non-competitive basis to University of Alabama at Birmingham, 701 S 20th Street, Birmingham, AL 35294-0001-0001, for research support to develop and validate circulating cell-free DNA (cfDNA) as a blood-based biomarker of chlorine-induced acute lung injury, using the Matalon Laboratory's sole-source validated murine chlorine inhalation injury model, established mechanistic expertise, access to its actively enrolling aspiration pneumonitis biorepository (human proxy cohort), existing collaborative
Show more
infrastructure with the NHLBI Laboratory of Precision Omics, and continuity with peer-reviewed federal funding (NIH R01 HL031197). These capabilities are not available from any other source and are essential to the project's feasibility. (iii)The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2026-01, effective 03/13/2026. (iv)The associated NAICS code is 541380, Testing Laboratories and Services, and the small business size standard is $19.0 million. This requirement is not set aside for small business.

From SAM.gov’s daily data file, as published on Nov 7, 2026 (UTC). SAM.gov’s latest daily file no longer lists this notice.

Contacts

Attachments

BidLookup records the links this notice gives. It has not downloaded or checked the files.

Record dates

Posted on SAM.gov: Oct 13, 2026
The agency’s publication date, as SAM.gov states it.
First recorded by BidLookup: Oct 15, 2026
The UTC day of the first read of SAM.gov’s listings that stored this notice.
Last confirmed: Nov 7, 2026
The UTC day of the latest read that still listed this notice. It does not mean the notice is unchanged or still open on SAM.gov now, and it is not the index’s last-read time.
Description as published: Nov 7, 2026 (UTC)
The date of the daily data file this text came from.

Published by the agency on SAM.gov as notice 66af16818b144456af1ddc0d52fc9378. What these dates mean

Record

Solicitation number
75N98027Q00007
Search the index for this number
NAICS
541380 · Testing Laboratories and Services
Product/service code
Q301 · REFERENCE LABORATORY TESTING
Contracting office
BETHESDA, MD 20892
SAM.gov notice ID
66af16818b144456af1ddc0d52fc9378